Flynn Pharma Ltd

Alton House, 4 Herbert Street, Dublin 2, Republic of Ireland,
Telephone: +353 1 209 0241
Fax: +353 1 288 3310
Medical Information Direct Line: +44 (0)1462 458 974
Customer Care direct line: +44 (0)1773 510 123
Medical Information Fax: + (0)1462 450 755
Patient Information Leaflet last updated on the eMC: 09/04/2009
PIL Actiq

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 09/04/2009 and displayed until Current
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 09/01/2009 and displayed until 09/04/2009
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 24/04/2008 and displayed until 09/01/2009
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 11/03/2008 and displayed until 24/04/2008
Reasons for adding or updating:
  • Change to MA holder contact details
  • Improved Electronic Presentation
Updated on 25/09/2007 and displayed until 11/03/2008
Reasons for adding or updating:
  • Change of licence holder
Updated on 26/09/2006 and displayed until 25/09/2007
Reasons for adding or updating:
  • Change of inactive ingredient
  • Change to warnings or special precautions for use
  • Change to date of revision
Updated on 09/01/2006 and displayed until 26/09/2006
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
  • Change to storage instructions
Updated on 31/07/2003 and displayed until 09/01/2006
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
   fentanyl


© 2010 Datapharm Communications Ltd

Go to www.medicines.org.uk